At almost $270 a pop, it’s probably no surprise that we get lots of questions about trying to find cheaper, more affordable sources for Actos. If you or a loved one suffers from Type 2 diabetes, Actos is one of the most commonly-prescribed prescription treatments, but unfortunately, it’s also one of the most pricey.
The . . . → Read More: Finding Cheaper, More Affordable Actos… Somewhere
Open Enrollment for Medicare Part D prescription drug coverage may be over, but extra help paying for your prescription drugs is still available. If you are on Medicare and are having trouble paying for your prescription drugs, you may qualify for the Medicare/Social Security Extra Help prescription drug program which can help you pay for . . . → Read More: Medicare Part D Open Enrollment May Be Over, But Extra Help For Prescription Drug Costs Still Available
Another reminder: Medicare Part D Open Enrollment season starts in less than a month away. Chances are, your current Medicare Part D plan and/or your prescription drug coverage options are changed, so if you haven’t started taking a look at your choices already, now is a good time to start.
Remember, you likely have dozens . . . → Read More: Open Enrollment Season: Have You Started Reviewing Your Medicare Part D Options?
Going into the long weekend, we thought we’d cheer on a few pharmaceutical companies who have done some good in making their prescription drugs and other products accessible to the world’s poor. GlaxoSmithKline, Merck, and Novartis again topped the Access to Medicine Index which ranks pharmaceutical companies on how readily that provide access of their . . . → Read More: GlaxoSmithKline, Merck and Novartis Top Study on Access of Prescription Drugs to the Poor